This article is more than 5 years old. Information may no longer be current.

Combined canaloplasty-phaco procedure shows reductions in medications, IOP

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN FRANCISCO — Performing canaloplasty in combination with phacoemulsification surgery resulted in good medication and IOP reduction in open-angle glaucoma patients, 2-year interim results of a multicenter study found.

"The 24-month data of combined phaco-canaloplasty is encouraging in that the sustained reduction of a significant amount has maintained for that 24-month period, and also, [there is a] profound decrease in the need for glaucoma medications," Bradford J. Shingleton, MD, said at the American Society of Cataract and Refractive Surgery meeting here.

Dr. Shingleton presented interim results of the prospective 3-year study of open-angle glaucoma patients who underwent combined phaco and canaloplasty. The 24-month data examined 23 patients.

Clinicians found that, at 24 months, patients had a 45% sustained reduction in IOP, at a mean of 13 mm Hg. Patients had an 85% sustained reduction in medications, at a mean of 0.2. In addition, patients had improved vision and no long-term complications after 3 months.